Anti-cancer
Dasatinib
CAS No.
302962-49-8
A multi-targeted tyrosine kinase inhibitor used in oral oncology formulations for chronic myeloid leukemia and acute lymphoblastic leukemia.
Dasatinib is a second-generation tyrosine kinase inhibitor API manufactured by NovaAcura Biotech under GMP-certified conditions. The company provides full batch documentation and regulatory support to global oncology formulation partners.
Applications & Uses
A multi-targeted tyrosine kinase inhibitor used in oral oncology formulations for chronic myeloid leukemia and acute lymphoblastic leukemia.
Full technical documentation, batch specifications and regulatory support (DMF/CEP) are available on request.
Need This Molecule at Scale?
Get in touch for pricing, lead times and full regulatory documentation.
Get In Touch